Open Access
Table 2
Outcomes of patients undergoing VA-ECLS using a univariable and multivariable regression analysis.
| Variables | Non-Hyperoxia Group | Hyperoxia Group | OR (95% CI) | p-value | aORa (95% CI) | Adjusted p-value |
|---|---|---|---|---|---|---|
| PaO2 ≤ 232 mmHg (n = 161) | PaO2 > 232 mmHg (n = 68) | |||||
| Mortality | 65 (40.4%) | 37 (54.4%) | 1.76 (0.995–3.12) | 0.052 | 2.02 (1.03–3.97) | 0.03 |
| Any Cardiovascular, Renal, or Mechanical complication | 113 (70.2%) | 54 (79.4%) | 1.29 (0.63–2.64) | 0.478 | 1.96 (0.89–4.35) | 0.10 |
| Stage II/III AKI** | 111 (74.5%) | 49 (79.0%) | 1.64 (0.83–3.23) | 0.154 | 2.12 (0.82–5.50) | 0.12 |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.